Aia1 |
Adjuvant induced arthritis QTL 1 |
joint integrity trait (VT:0010548)
|
Aia2 |
Adjuvant induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
Aia3 |
Adjuvant induced arthritis QTL 3 |
joint integrity trait (VT:0010548)
|
Aia4 |
Adjuvant induced arthritis QTL 4 |
joint integrity trait (VT:0010548)
|
Apr1 |
Acute phase response QTL 1 |
orosomucoid 1 amount (VT:0010541)
|
Apr2 |
Acute phase response QTL 2 |
blood murinoglobulin 1 amount (VT:0010597)
|
Apr3 |
Acute phase response QTL 3 |
blood interleukin-6 amount (VT:0008595)
|
Apr4 |
Acute phase response QTL 4 |
orosomucoid 1 amount (VT:0010541)
|
Apr5 |
Acute phase response QTL 5 |
blood interleukin-6 amount (VT:0008595)
|
Apr6 |
Acute phase response QTL 6 |
blood interleukin-6 amount (VT:0008595)
|
Ciaa1 |
CIA Autoantibody QTL 1 |
blood autoantibody amount (VT:0003725)
|
Ciaa2 |
CIA Autoantibody QTL 2 |
blood autoantibody amount (VT:0003725)
|
Ciaa3 |
CIA Autoantibody QTL 3 |
blood autoantibody amount (VT:0003725)
|
Eae1 |
Experimental allergic encephalomyelitis QTL 1 |
nervous system integrity trait (VT:0010566)
|
Eae10 |
Experimental allergic encephalomyelitis QTL 10 |
nervous system integrity trait (VT:0010566)
|
Eae11 |
Experimental allergic encephalomyelitis QTL 11 |
nervous system integrity trait (VT:0010566)
|
Eae12 |
Experimental allergic encephalomyelitis QTL 12 |
nervous system integrity trait (VT:0010566)
|
Eae13 |
Experimental allergic encephalomyelitis QTL 13 |
nervous system integrity trait (VT:0010566)
|
Eae14 |
Experimental allergic encephalomyelitis QTL 14 |
nervous system integrity trait (VT:0010566)
|
Eae15 |
Experimental allergic encephalomyelitis QTL 15 |
nervous system integrity trait (VT:0010566)
|
Eae19 |
Experimental allergic encephalomyelitis QTL 19 |
nervous system integrity trait (VT:0010566)
|
Eae20 |
Experimental allergic encephalomyelitis QTL 20 |
nervous system integrity trait (VT:0010566)
|
Eae21 |
Experimental allergic encephalomyelitis QTL 21 |
body mass (VT:0001259)
|
Eae22 |
Experimental allergic encephalomyelitis QTL 22 |
nervous system integrity trait (VT:0010566)
|
Eae4 |
Experimental allergic encephalomyelitis QTL 4 |
nervous system integrity trait (VT:0010566)
|
Eae5 |
Experimental allergic encephalomyelitis QTL 5 |
nervous system integrity trait (VT:0010566)
|
Eae6 |
Experimental allergic encephalomyelitis QTL 6 |
body mass (VT:0001259)
|
Eae7 |
Experimental allergic encephalomyelitis QTL 7 |
body mass (VT:0001259)
|
Eae8 |
Experimental allergic encephalomyelitis QTL 8 |
nervous system integrity trait (VT:0010566)
|
Eae9 |
Experimental allergic encephalomyelitis QTL 9 |
body mass (VT:0001259)
|
Eaex |
Experimental allergic encephalomyelitis QTL x |
nervous system integrity trait (VT:0010566)
|
Eaey |
Experimental allergic encephalomyelitis QTL y |
nervous system integrity trait (VT:0010566)
|
Eaez |
Experimental allergic encephalomyelitis QTL z |
nervous system integrity trait (VT:0010566)
|
Iddm16 |
Insulin dependent diabetes mellitus QTL 16 |
blood glucose amount (VT:0000188)
|
Iddm4 |
Insulin dependent diabetes mellitus QTL 4 |
blood glucose amount (VT:0000188)
|
Iddm5 |
Insulin dependent diabetes mellitus QTL 5 |
blood glucose amount (VT:0000188)
|
Iddm6 |
Insulin dependent diabetes mellitus QTL 6 |
blood glucose amount (VT:0000188)
|
Nka1 |
Natural killer alloreactivity QTL 1 |
natural killer cell cytolysis trait (VT:0005070)
|
Oia2 |
Oil induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
Pia1 |
Pristane induced arthritis QTL 1 |
joint integrity trait (VT:0010548)
|
Pia2 |
Pristane induced arthritis QTL 2 |
joint integrity trait (VT:0010548)
|
Pia3 |
Pristane induced arthritis QTL 3 |
joint integrity trait (VT:0010548)
|
Pia4 |
Pristane induced arthritis QTL 4 |
joint integrity trait (VT:0010548)
|
Pia5 |
Pristane induced arthritis QTL 5 |
joint integrity trait (VT:0010548)
|
Pia6 |
Pristane induced arthritis QTL 6 |
joint integrity trait (VT:0010548)
|
Tcas10 |
Tongue tumor susceptibility QTL 10 |
tongue integrity trait (VT:0010553)
|
Tcas11 |
Tongue tumor susceptibility QTL 11 |
tongue integrity trait (VT:0010553)
|
Tcas2 |
Tongue tumor susceptibility QTL 2 |
tongue integrity trait (VT:0010553)
|
Tcas3 |
Tongue tumor susceptibility QTL 3 |
tongue integrity trait (VT:0010553)
|
Tcas4 |
Tongue tumor susceptibility QTL 4 |
tongue integrity trait (VT:0010553)
|
Tcas5 |
Tongue tumor susceptibility QTL 5 |
tongue integrity trait (VT:0010553)
|
Tcas6 |
Tongue tumor susceptibility QTL 6 |
tongue integrity trait (VT:0010553)
|
Tcas8 |
Tongue tumor susceptibility QTL 8 |
tongue integrity trait (VT:0010553)
|
Tcas9 |
Tongue tumor susceptibility QTL 9 |
tongue integrity trait (VT:0010553)
|